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In previous work, we have described an early-activated and ultraviolet B (UVB)-induced apoptotic pathway in
human keratinocytes, which can be completely inhibited by AKT activation. We now compared this response of
primary human keratinocytes with the response of two p53-mutated squamous cell carcinoma (SCC)-derived cell
lines (A431 and A253) to an apoptotic UVB dose. In these cell lines, both the basal AKT phosphorylation status and
the apoptotic response to UVB diverged strongly from the response of healthy primary keratinocytes. Even more, a
remarkable correlation was found between the two. Although a constitutive dual phosphorylation of AKT rendered
the A253 SCC cell line completely resistant to the early-activated and UVB-induced apoptotic pathway, deﬁcient
T308 phosphorylation of AKT in the SCC cell line A431 led to a greatly augmented sensitivity to the early-activated,
UVB-induced apoptotic pathway. These results indicate that the preservation of a healthy AKT pathway is essential
for a wild-type UVB-induced apoptotic response in skin, and suggest that AKT-mediated dysregulation of the early-
activated apoptotic response to UVB is an important event in the oncogenic transformation of keratinocytes.
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A controlled insulin-like growth factor-1 (IGF-1)–AKT signal-
ing pathway is critical for preserving cellular homeostasis.
Uncontrolled activation of this kinase is closely linked with
tumor promotion (Segrelles et al, 2002). Elimination of DNA-
damaged cells is an essential process that reduces the
risk of malignant conversion. (DiGiovanni et al, 2000) AKT
induces a strong survival response. This allows cells to
withstand a wide variety of stress types (Decraene et al,
2002) but could also make cells more susceptible to
mutation.
In a previous study, we have explored this survival-promo-
ting effect of activated AKT on ultraviolet B (UVB)-damaged
normal human keratinocytes and have demonstrated that
human keratinocytes trigger not one but two major
apoptotic programs in response to UVB. A first, early-
activated program is triggered within the first 3 h after UVB-
irradiation and can be completely inhibited by IGF-1–AKT
signaling. A second, late-induced program is triggered 10–
14 h after UVB-irradiation, is impervious to IGF-1–AKT
signaling, and might be seen as a fail-safe mechanism. As a
consequence, apoptosis in IGF-1 stimulated cells, but not in
growth factor-deprived cells, is postponed by more than 7
h. Activation of AKT subsequently gives the cells more time
for DNA repair, weakens the apoptotic stimulus and there-
fore allows keratinocytes to withstand higher UVB doses
(Decraene et al, 2002).
But dysregulation of the IGF-1–AKT pathway is fre-
quently observed in tumorigenic cells. On the one hand, the
IGF-1 axis itself is a frequent target for mutation (Aoki et al,
1998). Phosphatase and tensin homolog (PTEN), for
example, is mutated in about 60% of all cancers (Yoga-
nathan et al, 2000). On the other hand, wild-type (wt)-p53
plays an important role in keeping IGF-1 signaling to a
minimum. Both IGF-1-binding protein 3 (IGF-BP3) expres-
sion and IGF-1 receptor (IGF-1R) repression, two factors
that limit IGF-1 signaling, are dependent on functional wt-
p53 (Buckbinder et al, 1995; Werner et al, 1996). p53 is also
involved in the transcriptional repression of the catalytic
subunit (p110) of phosphaditylinositol 3-kinase (PI3-K),
another component of the AKT signaling pathway (Singh
et al, 2002). Furthermore, p53 transactivates the PTEN gene
(Stambolic et al, 2001). PTEN dephosphorylates the lipid
second messenger PI(3,4,5)P3, a product of PI3-K activity,
thereby negatively regulating AKT signaling. Tumor sup-
pressor p53 gene mutation is, however, a common and
early event in human cancers (Hernandez-Boussard et al,
1999). One can thus expect that downregulation of the IGF-
1–AKT signaling pathway by p53 is lost in cells expressing
mutated forms of p53.
In this study, we looked at the responsiveness of two
p53-mutated squamous cell carcinoma (SCC)-derived cell
lines, the A253 and the A431 cell line, to the UVB-induced,
early-activated apoptotic pathway. Dysregulation of the
AKT pathway in these cell lines drastically altered the
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apoptotic response to UVB-irradiation in a p53-independent
fashion. Our study confirms the vital role of a strictly
regulated IGF-1–AKT signaling pathway in the preservation
of a healthy skin. Furthermore, our data identify the AKT-
mediated dysregulation of the early-activated and UVB-
induced apoptotic pathway as a key event in the oncogenic
transformation of the skin.
Results
Basal AKT and p53 protein levels in A253 and A431
cells In previous work, we have demonstrated that the
activation of the AKT kinase in human keratinocytes can
alter the outcome of the response of keratinocytes to UVB
damage, by postponing the early induction (o3 h) of
apoptosis by more than 7 h (Decraene et al, 2002). Although
AKT activation is under strict regulation in healthy human
skin, tumor promotion often relates with uncontrolled
activation of this kinase. In this study, we therefore wished
to investigate whether an IGF-1 regulated wild-type
apoptotic response to UVB damage is conserved in two
SCC cell lines, the A431 and the A253 cell line.
For this purpose, all experiments were conducted in the
absence of growth factors. Basal AKT protein levels were
examined first. As shown in Fig 1, western blot analysis
indicates that basal protein levels of AKT are somewhat
reduced in A431 cells, and even more in A253 cells when
compared with normal human keratinocytes (Fig 1).
Of interest, both cell lines each contain only one p53
allele (Reiss et al, 1992). Furthermore, A253 cells no longer
express any p53 mRNA, possibly due to mutations in the
regulatory region of the remaining p53 allele (Reiss et al,
1992). Concomitantly, no p53 protein can be detected in
this cell line (Fig 1, A253 p53()). To evaluate the importance
of p53 loss for a potential dysregulation of the AKT kinase
pathway in A253 cells, we stably re-integrated wt-p53
cDNA into the genome of the A253 cell line by retroviral
transfer (Courtois et al, 1997). Retroviral transfection
restored p53 protein levels in these cells (Fig 1, A253
p53(þ )) but did not affect AKT total protein level. The higher
p53 protein level in unstressed A431 cells when compared
with normal human keratinocytes (Fig 1) can be accounted
to an increased half-life of the p53 protein. Due to mutation,
increased p53 protein levels in cutaneous neoplasms are
frequently observed (Onodera et al, 1996).
A431 cells are sensitized to the early-activated pathway
of apoptosis Previous work has demonstrated that pri-
mary keratinocytes show morphological and biochemical
signs of apoptosis as soon as 3 h after UVB-irradiation,
when deprived of IGF-1 (Decraene et al, 2002). When grown
in the presence of IGF-1, primary keratinocytes are
protected against this early induction of apoptosis and
display apoptosis at much later time points (10–14 h)
following UVB-irradiation. The time course for the induction
of apoptosis was evaluated by pre-incubating A431 cells in
the absence or in the presence of IGF-1 (30 min) and
subsequently exposing them to a pro-apoptotic UVB-dose
(100 mJ per cm2). Western blot analysis of caspase-
3-induced PARP cleavage, a biochemical marker for the
induction of apoptosis, revealed that, in the absence of IGF-
1 stimulation, A431 cells display a similar time frame for the
induction of apoptosis compared with primary keratino-
cytes (Fig 2A). Upon growth factor deprivation, PARP
cleavage can first be observed from 3 h following UVB-
irradiation. But in marked contrast to primary keratinocytes,
IGF-1 supplementation does not rescue A431 cells from the
early-activated apoptotic pathway in A431 cells (Fig 2A).
Chromatin condensation, a morphological marker of the
apoptotic process, was also monitored by staining A431
cells with the Hoechst 33342 fluorescent dye. The early
appearance of cells with condensed chromatin (5 h after
UVB-irradiation) in both growth factor-deprived and IGF-1-
supplemented A431 cultures (Fig 2Ba–c) again demon-
strates that IGF-1 supplementation is unable to protect
A431 cells against the early-activated apoptotic pathway.
The presence of sub-G1 DNA content, another marker of
the apoptotic process, was analyzed by flow cytometric
analysis of Sytox green-stained cells. Five hours after UVB-
irradiation, a sub-G1 fraction could be observed not only in
growth factor-deprived but also in IGF-1-supplemented
A431 cells (Fig 2Bd–f ). The presence of sub-G1 DNA
content again confirmed that UVB-irradiated A431 cells are
sensitized to the early-activated apoptotic pathway.
In the absence of wortmannin treatment, A253 cells are
completely resistant to the early-activated pathway of
apoptosis The apoptotic response of A253 cells to UVB
differed from the response of both A431 cells and primary
human keratinocytes. Western blot analysis of caspase-3-
induced PARP cleavage demonstrates that, even in the
absence of IGF-1 stimulation, A253 cells have become
completely resistant against the early-activated apoptotic
pathway (Fig 3A). These cells undergo apoptosis at much
later time points, again in marked contrast with healthy
human keratinocytes, which rely on IGF-1-mediated AKT
activation for a complete protection against early-activated
apoptosis in response to UVB.
A former study demonstrated a decrease in the
malignant phenotype of A253 cells and a re-establishment
of the G1 checkpoint upon re-expression of wt-p53
(Courtois et al, 1997). Stable re-expression of wt-p53,
however, did not re-sensitize A253 cells to early UVB-
induced apoptosis (Fig 3A). No PARP cleavage could be
observed within the first 6 h after UVB-irradiation. Sensitivity
to the early-activated apoptotic pathway could only be
restored when A253 cells were pre-treated with 1 mM
Figure 1
Basal p53 and AKT protein levels in normal human keratinocytes
(NHK), A253, and A431 cells. Primary human keratinocytes (NHK),
A253 cells (A253 p53()), A253 cells stably re-expressing wild type p53
(A253 p53(þ )) and A431 cells (A431) were lysed and subjected to an
SDS-PAGE. p53 and AKT proteins levels were analyzed by immuno-
blotting with anti-p53 and anti-AKT antiserum as described under
‘‘Materials and Methods’’.
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wortmannin before UVB-irradiation (Fig 3B). Both Hoechst
staining and cell cycle analysis confirmed these observa-
tions. Five hours after UVB-irradiation (100 mJ per cm2), no
chromatin condensation could be observed in growth
factor-deprived A253 cells (Fig 3Ca, c). In concurrence, no
sub-G1 peak could be observed under these conditions
(Fig 3Ce,g). A 1 h pre-treatment with 1 mM wortmannin did,
however, re-sensitize A253 cells to the early-activated
apoptotic pathway, as demonstrated by the appearance
of cells with condensed chromatin (Fig 3Cb,d ) and the
presence of sub-G1 DNA content (Fig 3Bf, h).
Sensitivity of SCC cell lines to the UVB-induced,
early-activated apoptotic pathway correlates with the
phosphorylation status of AKT In healthy human kerati-
nocytes, the activation status of AKT defines whether
keratinocytes are sensitive or resistant against the early-
activated apoptotic pathway to UVB (Decraene et al, 2002).
For this reason, we looked at the phosphorylation status of
AKT in both SCC cell lines. Both A431 and A253 cells
(A253-p53() and A253-p53(þ )) were raised in growth
factor-deprived media and subsequently exposed to IGF-1
for 15 min. The phosphorylation status of AKT was then
analyzed by immunoblotting with phospho-specific anti-
bodies. A431 cells were examined first. In contrast to
healthy human keratinocytes, the S473 site of AKT was
phosphorylated in A431 cells in the absence of IGF-1
supplementation (Fig 4A). The addition of IGF-1 further
increased the phosphorylation of the S473 site. We were,
however, unable to detect any phosphorylation at the T308
site of AKT in the A431 cells, either with or without IGF-1
supplementation (Fig 4A).
A253 cells displayed an apparent constitutive S473
phosphorylation, as S473 phosphorylation was observed
even in the absence of IGF-1 supplementation and hardly
increased upon the addition of IGF-1 (Fig 4A). Remarkably,
however, the T308 site was phosphorylated, even when
cells were deprived of IGF-1 stimulation (Fig 4A). The
addition of IGF-1 further increased this phosphorylation.
Stable re-expression of wt-p53 did not alter T308 or S473
phosphorylation of AKT in A253 cells (Fig 4A, A253-
p53(þ )).
We next investigated whether a treatment with wortman-
nin, an irreversible inhibitor of PI3-K, would be able to inhibit
AKT phosphorylation in growth factor-deprived A253 cells.
Treatment with 1 mM wortmannin did indeed completely
inhibit T308 phosphorylation in both A253 p53-negative and
p53-postive cells (Fig 4B). Surprisingly, wortmannin treat-
ment had no effect on the phosphorylation of the S473 site.
Discussion
We have recently characterized a novel, early-activated
pathway for the induction of apoptosis in UVB-irradiated
primary human keratinocytes. This early-activated pathway
of apoptosis is triggered within the first 3 h following UVB-
irradiation, but only in the complete absence of IGF-1R
signaling. Activation of the AKT kinase, through IGF-1
signaling, fully rescues keratinocytes from this early induc-
tion of apoptosis. Cells then undergo apoptosis at much
later time points (410 h after UVB-irradiation). This delay
grants the cell more time for the removal of DNA photo-
lesions, and as a result, allows keratinocytes to endure
higher doses of UVB-irradiation (Decraene et al, 2002).
A controlled apoptotic response is vital for skin cells, as it
prevents replication of cells containing damaged DNA,
without causing gratuitous cell death. The AKT signaling
pathway, however, has been increasingly documented as a
prime determinant of tumor promotion and progression in
several cell types, including skin (Segrelles et al, 2002).
Consequently, AKT-dependent dysregulation of the apop-
totic response to UVB could be a key event in the multistep
process of skin carcinogenesis. To find support for this
hypothesis, we examined the apoptotic response and the
Figure 2
Growth factor-deprived A431 cells are sensitized to the early-
activated and ultraviolet B (UVB)-induced apoptotic pathway.
A431 cells were cultured in growth factor-deprived medium as
described in ‘‘Materials and Methods’’. (A) Western blot analysis
of the time course for caspase-3-induced poly(ADP-ribose)poly-
merase (PARP) cleavage in UVB-irradiated (100 mJ per cm2)
A431 cells. Lysates were collected at the indicated time points.
(B) (a–c) Microscopic images of cells stained with Hoechst dye,
taken 5 h after irradiation with 100 mJ per cm2 UVB (arrows
indicate cells with condensed chromatin). (d–f ) Cell cycle
analysis of A431 cells, 5 h after irradiation with 100 mJ per cm2
UVB. Growth factor-deprived A431 cells were sham-irradiated
(a, d ), UVB-irradiated (b, e), or supplemented with insulin-like
growth factor-1 (IGF-1) and UVB-irradiated (c, f ). In all of the
above experiments, IGF-1 (10 ng per mL) was added 30 min
before UVB-irradiation.
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AKT phosphorylation status of two SCC-derived cell lines,
the A431 and the A253 cell line.
We found that both cell lines exhibited an apoptotic
response to UVB, which deviated from that of healthy
human keratinocytes. On the one hand, morphological and
biochemical analysis demonstrated that the protective
effect of IGF-1 supplementation was lost in the A431 cell
line. When irradiated with a pro-apoptotic UVB-dose, these
cells undergo apoptosis as soon as 3 h following irradiation,
even in the presence of IGF-1 stimulation. A253 cells, on the
other hand, were found to be completely resistant against
this early-activated apoptotic pathway. Even in the com-
plete absence of IGF-1 stimulation, induction of apoptosis is
postponed to much later time points in UVB-irradiated
A253 cells.
As previous work had demonstrated that the protection
against the early (o3 h) activation of apoptosis relies upon
AKT activation, an answer to the dysregulated apoptotic
response of both cell lines was sought by looking at the
phosphorylation status of AKT. Two phosphorylation sites,
vital for the activation of AKT in response to IGF-1
stimulation, were examined. The main site of phosphoryla-
tion can be found at T308. Without this specific phos-
phorylation, the activity of AKT is greatly impaired (Alessi
et al, 1996; Scheid and Woodgett, 2003). Additionally, the
catalytic activity of the AKT kinase can be further increased
through the phosphorylation of a second residue, the S473
residue. A sustained double phosphorylation of the AKT
kinase, at the T308 and S473 residues, is absolutely
required for the activation of this kinase (Alessi et al,
1996).
A first observation is that both SCC-derived cell lines
displayed S473 phosphorylation of AKT in the absence of
growth factors. Furthermore, the level of S473 phosphor-
ylation in A253 cells deprived of growth factors was almost
indistinguishable from that of IGF-1-supplemented A253
cells, suggesting a constitutive phosphorylation of the S473
residue in these cells. Indeed, constitutive S473 phosphor-
ylation has been repeatedly reported for many human
cancer types, including non-small-cell lung cancer, colon
cancer, and pancreatic cancer (Brognard et al, 2001). The
phosphorylation of the T308 residue differed strongly,
however, and showed a remarkable correlation with the
level of protection against the early-activated apoptotic
pathway to UVB.
Even in the presence of IGF-1 stimulation, A431 cells
were unable to phosphorylate the T308 residue. As
phosphorylation of the T308 residue is an absolute
necessity for the activation of the AKT kinase (Alessi et al,
1996; Scheid and Woodgett, 2003), the absence of T308
phosphorylation would render the AKT kinase inactive. This
is indeed reflected by the fact that these cells are no longer
rescued from the early (o3 h) induction of apoptosis
following UVB-irradiation when supplemented with IGF-1
(Figs 2 and 4A).
In absolute contrast, phosphorylation of the T308 residue
could be observed even in the absence of IGF-1 stimulation
in A253 cells. The addition of IGF-1 further increased this
Figure 3
Growth factor-deprived A253 cells are
completely resistant to the early-acti-
vated and ultraviolet B (UVB)-induced
apoptotic pathway, in a wortmannin-
sensitive fashion. A253 cells were
cultured in growth factor-deprived med-
ium as described in ‘‘Materials and
Methods’’. (A) Western blot analysis of
the time course for caspase-3-induced
poly(ADP-ribose)polymerase (PARP) clea-
vage in UVB-irradiated (100 mJ per cm2)
A253 cells lacking endogenous p53-
expression (A253-p53()) and cells sta-
bly re-expressing wild-type (wt)-p53
(A253-p53(þ )). Cell lysates were col-
lected at the indicated time points. (B)
A253 cells (stably re-expressing wt-p53
were indicated) were pre-treated with 1
mM wortmannin for 1 h and subsequently
exposed to 100 mJ per cm2 UVB. Cell
lysates were collected at the indicated
time points. PARP cleavage was ana-
lyzed by western blotting as described.
(C) (a–d) Microscopic images of cells
stained with Hoechst dye, taken 5 h after
irradiation with 100 mJ per cm2 UVB
(arrows indicate cells with condensed
chromatin). (e–h) Cell cycle analysis of
growth factor-deprived A253 cells, 5 h
after irradiation with 100 mJ per cm2
UVB. (a, e) A253-p53() cells, (b, f)
A253-p53() cells pre-treated with 1
mM wortmannin, (c, g) A253-p53(þ )
cells, (d, h) A253-p53(þ ) cells pre-
treated with 1 mM wortmannin.
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phosphorylation. Correspondingly, even in the absence of
IGF-1 supplementation, A253 cells were completely pro-
tected from the early induction of apoptosis following UVB-
irradiation (Figs 3 and 4A). The possibility that this growth
factor-independent dual phosphorylation was the main
cause for the observed resistance against the early-
activation of apoptosis following UVB was confirmed
through experiments with wortmannin, an irreversible PI3-
K inhibitor. Although a pre-treatment with wortmannin had
no obvious effect on the phosphorylation of the S473
residue of AKT, T308 phosphorylation was completely
abrogated. Furthermore, morphological and biochemical
analysis demonstrated that inhibition of T308 phosphoryla-
tion by wortmannin pre-treatment re-sensitized A253 cells
to the early-activated apoptotic pathway (Figs 3 and 4B).
Consequently, the changes in the apoptotic res-
ponse, observed in both cell lines, are inherent to a
dysregulation of the AKT signaling pathway. Not only do
these data therefore indicate that AKT dysregulation might
be a frequent event in skin carcinogenesis, they point out
that one of the most significant repercussions of AKT
dysregulation in the skin is the dysregulation of the
apoptotic response to UVB.
In addition, several papers have described a negative
regulatory interaction between p53 and the AKT kinase
pathway (Buckbinder et al, 1995; Stambolic et al, 2001;
Zhou et al, 2001; Singh et al, 2002). As A253 cells do not
contain endogenous p53, it was therefore of interest to
examine the effect of stable re-expression of wt-p53 in
these cells. We found no direct evidence for a down-
regulation of the AKT kinase pathway upon re-expression of
p53. More importantly, these data might indicate that the
early-activated pathway of apoptosis in response to UVB
does not require functional p53.
In conclusion, both p53-mutated SCC cell lines exhibited
an apoptotic response that deviated strongly from the
response of healthy human keratinocytes. We demonstrate
that stability and preservation of the AKT kinase path-
way are essential for a normal IGF-1 sensitive apoptotic
response to UVB in the skin. Our data suggest that AKT-
mediated dysregulation of the apoptotic process is a
common event in skin photocarcinogenesis. Targeting the
AKT kinase pathway could therefore be a valuable thera-
peutic strategy in the fight against skin cancer.
Materials and Methods
Cell culture Primary human keratinocytes were isolated from
foreskins of young donors (less than 6 y) as described (Gilchrest,
1983). Third to fifth passage cells were used in experiments. The
procedure has been approved by the ethical committee of the
university of Leuven. The A253 human SCC line (American Type
Culture Collection, Manassas, Virginia) was derived from a human
head and neck SCC. The A253 cell line was chosen for its lack of
endogenous p53 expression. The A431 human SCC cell line
(American Type Culture Collection) was derived from vulvar SCC.
Stable retroviral-mediated infection of A253 cells with full-length
human wt-p53 was performed as previously described (Courtois
et al, 1997). Keratinocytes were initially grown in serum-free and
growth factor-containing medium (Keratinocyte-SFM; Invitrogen,
Merelbeke, Belgium), which harbors several growth factors (insulin
(5 mg per mL), hydrocortisone (74 ng per mL), triiodo-L-thyronine
(6.7 ng per mL), bovine pituitary extract (50 mg per mL), and human
recombinant epidermal growth factor (5 ng per mL)). Cells were
deprived of growth factors when they reached 40% confluency, by
washing twice with phosphate-buffered saline (PBS), followed by
an incubation of 48 h with serum-free keratinocyte basal medium
(Cambrex Bioproducts, Boechout, Belgium), deficient in the above-
stated growth factors. IGF-1 and wortmannin were purchased from
Sigma-Aldrich (Bornem, Belgium).
UVB-irradiation Prior to UVB-irradiation, cells were washed twice
with PBS, were then irradiated through a thin film of PBS, and re-
fed with their own medium. Cells were exposed through the cover
of the dish, which filters out residual UVC (Brown et al, 2001). The
Figure 4
Sensitivity of squamous cell carcinoma cell
lines to the early-activated and ultraviolet B
(UVB)-induced apoptotic pathway correlates
with the AKT phosphorylation status. Cells
were cultured in growth factor-deprived medium
as described under ‘‘Materials and Methods’’.
(A) AKT phosphorylation status was evaluated by
western blotting. Following a 15 min incubation in
the absence or in the presence of insulin-like
growth factor-1 (IGF-1) (10 ng per mL), cell lysates
were collected. Proteins were separated by SDS-
PAGE and analyzed by immunoblotting as de-
scribed in ‘‘Materials and Methods’’. NHK, normal
human keratinocytes; A253-p53(), A253 cells
that lack endogenous p53 expression; A253-
p53(þ ), A253 cells stably re-expressing wild-type
(wt)-p53. (B) A253 cells lacking endogenous p53
expression () and A253 cells stably re-expressing
wt-p53 (þ ) were treated with Wortmannin (1 mM)
and scraped at the indicated time point. AKT
phosphorylation status was evaluated by immu-
noblotting with phospho-specific antibodies as
described under ‘‘Materials and Methods’’.
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UVB source was a parallel bank of three Philips TL 20W12 tubes
(Dermat BVBA, Heverlee, Belgium) with a peak output around
310 nm. Output was measured through the cover of a tissue culture
dish with an IL700 radiometer (International light, Newburyport,
Massachusetts).
Western blotting At the indicated time points, cells were scraped
in lysis buffer (25 mM HEPES, 0.3 mM NaCl, 1.5 mM MgCl2, 20 mM
b-glycerolphosphate, 2 mM EDTA, 2 mM EGTA, pH 7.5) containing
1% Triton, 10% glycerol, 1 mM Na3VO4, 0.5 mM DTT, 10 mg per mL
Leupeptin, 10 mg per mL Aprotinin, and 10 mg per mL Antipain.
Extracts were incubated on ice and spun down at 17,000 g. for
20 min. Protein concentration was determined using the BCA
Protein Assay Reagent (Pierce Chemical Company, Rockford,
Illinois). Twenty to fifty micrograms of total protein extract was
separated by a 10% SDS-PAGE, followed by wet electrotransfer
onto Hybond-C Super membrane (Amersham Pharmacia, Roo-
sendaal, The Netherlands). Equal loading of proteins was verified
using Ponceau-S in coloring (Klein et al, 1995). Membranes were
blocked for 1 h at room temperature in Tris-buffered saline (TBS)
containing 0.1% Tween and 5% non-fat dry milk. The membrane
was incubated overnight at 41C with the primary antibody, washed
and incubated for 1 h at room temperature with the peroxidase-
conjugated secondary antibody. Protein bands were visualized
using enhanced chemiluminescence as described by the supplier
(Amersham Pharmacia). Monoclonal anti-human poly(ADP-ribo-
se)polymerase (PARP) and monoclonal anti-human p53 (Clone
DO1) were purchased from Pharmingen (BD Biosciences, Erem-
bodegem, Belgium); polyclonal anti-pS473 AKT was purchased
from Promega (Leiden, The Netherlands). Polyclonal anti-AKT and
polyclonal phospho-AKT (T308) antibodies were purchased from
Cell Signaling (Beverly, Massachusetts).
Cell cycle analysis and Hoechst staining DNA content was
measured by fluorescence-activated cell sorting (FACS). Cells were
collected by trypsinization at the appropriate time point. After
centrifugation, cells were fixed overnight in 70% ethanol at 201C.
Following centrifugation, cells were incubated for 5 min in DNA
extraction buffer containing 0.2 M Na2HPO4, pH 7.8, and 0.1 M citric
acid. After a final centrifugation step, cells were stained for 30 min
at room temperature with 1 mM Sytox green (Molecular probes,
Eugene, Oregon) in the presence of 0.2 mg per mL DNase-free
RNase A. Cells were analyzed by flow cytometry using a 488 nm
argon laser for excitation. Green fluorescence was measured at
525 nm (FACS Calibur, Becton Dickinson, Mountain View, Cali-
fornia). For each sample, 15,000 cells were measured. The data
obtained were analyzed with the EXPO32 MultiCOMP software.
Nuclear changes were visualized by staining the cells for 10 min
with the Hoechst 33342 dye (3 mM in PBS), followed by examin-
ation under a fluorescence microscope. Unless stated otherwise,
all reagents were obtained from Sigma-Aldrich.
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